CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | +50.0% | 160 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -80.0% | 160 | -80.0% | 0.00% | – |
| Q4 2019 | $10,000 | -9.1% | 800 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | +22.2% | 800 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -95.1% | 800 | -94.9% | 0.00% | -100.0% |
| Q1 2019 | $184,000 | -83.6% | 15,700 | -81.3% | 0.01% | -85.7% |
| Q4 2018 | $1,121,000 | +1159.6% | 83,900 | +1453.7% | 0.04% | +1300.0% |
| Q1 2018 | $89,000 | -92.7% | 5,400 | -92.0% | 0.00% | -93.3% |
| Q4 2017 | $1,227,000 | -11.9% | 67,900 | -5.9% | 0.04% | -26.2% |
| Q3 2017 | $1,393,000 | +87.5% | 72,150 | +14.5% | 0.06% | +90.6% |
| Q2 2017 | $743,000 | -48.7% | 63,000 | -88.3% | 0.03% | -82.8% |
| Q3 2014 | $1,447,000 | -4.3% | 540,000 | 0.0% | 0.19% | -24.7% |
| Q2 2014 | $1,512,000 | – | 540,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |